APA (7th ed.) Citation

Minckwitz, G. v., Schneeweiss, A., Loibl, S., Salat, C., Denkert, C., Rezai, M., . . . Untch, M. (2014). Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): A randomised phase 2 trial. The lancet <London> / Oncology, 15(7), .

Chicago Style (17th ed.) Citation

Minckwitz, Gunter von, et al. "Neoadjuvant Carboplatin in Patients with Triple-negative and HER2-positive Early Breast Cancer (GeparSixto; GBG 66): A Randomised Phase 2 Trial." The Lancet <London> / Oncology 15, no. 7 (2014).

MLA (9th ed.) Citation

Minckwitz, Gunter von, et al. "Neoadjuvant Carboplatin in Patients with Triple-negative and HER2-positive Early Breast Cancer (GeparSixto; GBG 66): A Randomised Phase 2 Trial." The Lancet <London> / Oncology, vol. 15, no. 7, 2014.